Unknown

Dataset Information

Larotrectinib in a NTRK-rearranged soft tissue sarcoma in the neoadjuvant setting: A case report.


ABSTRACT: Patients with soft tissue sarcomas should be assessed for neurotrophic tropomyosin receptor kinase (NTRK) gene fusions as neoadjuvant treatment with larotrectinib may prevent amputation.

SUBMITTER: Percy C 

PROVIDER: S-EPMC7981750 | biostudies-literature | 2021 Mar

REPOSITORIES: biostudies-literature